Date: Jan 05, 2009 Source: (
click here to go to the source)
DENVER, Jan. 5 /PRNewswire/ -- Pharmatech, Inc. announces the launch of a
new campaign, Pharmatech 2.0, to highlight the company's focus in oncology,
along with other key company developments that will take place in early
January 2009. The next generation of Pharmatech will feature a name change
from Pharmatech, Inc. to Pharmatech Oncology, Inc., as well as a new web site
and emerging roles and responsibilities of the executive leadership team.
With the start of 2009, all business will be managed under the name
Pharmatech Oncology, Inc. The Pharmatech Board of Directors implemented the
name change from the parent company of Pharmatech, Inc. to the subsidiary name
of Pharmatech Oncology. Anders Malm, current President, states, "There was a
need in the marketplace for better recognition of what type of business
Pharmatech was involved in. Changing from Pharmatech to Pharmatech Oncology
relays a core understanding that Pharmatech works within the cancer arena."
The leadership team at Pharmatech Oncology will also be undergoing a
transformation in roles and titles. Current Chief Executive Officer, Matthew
B. Wiener, PharmD, will now take over the daily business operations under the
title Chairman and Chief Operating Officer. Anders Malm, current President,
will now replace Dr. Wiener as CEO. Pharmatech Oncology also welcomes Rob
Bohacs as the new Corporate Development Manager.
Pharmatech Oncology will also introduce a new web site,
http://www.pharmatechoncology.com. The launch of the new web site will
showcase a more functional format, along with easy navigation capabilities.
The current web site http://www.pharmatech.com will point to the new address
at http://www.pharmatechoncology.com.
About Pharmatech Oncology:
Pharmatech Oncology, headquartered in Denver, Colorado, is a Research
Management Organization (RMO) dedicated to the highest quality of clinical
research. Pharmatech Oncology provides services of a Site Management
Organization (SMO) and a Contract Research Organization (CRO) with a focus in
oncology clinical trials. Through an organized research network, the Company
focuses on the development and utilization of therapeutic products among
sponsors, investigators, and patients. For more information about Pharmatech
Oncology, please visit www.pharmatechoncology.com.
SOURCE Pharmatech, Inc.
Kristi Pohly, Marketing Manager of Pharmatech, Inc., +1-720-917-8400,
kristip@pharmatech.com
